The ride-share company plans to sell $10 billion in stock. Sources told Reuters the sale could value Uber at up to $100 billion, lower than the $120 billion initially expected by investment bankers due to the poor performance of Lyft’s IPO. Uber lost $1.8 billion in 2018, excluding some transactions, The New York Times reports.
Five notes on Uber’s role in healthcare:
- Uber began its healthcare journey in March 2018 with the launch of Uber Health, which allows healthcare providers to arrange scheduled and on-demand rides for patients with and without smartphones.
- Uber Health’s application programming interface can be integrated into existing healthcare software or used on any internet-enabled device.
- The service is HIPAA-compliant. Here’s how HIPAA applies.
- The company sees healthcare laws and regulations as a potential area of risk as it continues to expand its nonemergency medical transportation offerings.
- The company faces a greater uphill battle on brand perception than its competitor, Lyft, which it references in the IPO. It currently faces a number of investigations and other inquiries, including one alleged case of inappropriately accessing a rape victim’s medical records.
For more on ride-sharing in healthcare, check out why some medical professionals oppose it, and four notes on Lyft’s healthcare work.
More articles on health IT:
Theranos granted 5 new patents
Northwell Health physician wins $1M grant for clinical decision support tool
New tech is sparking a revolution for the healthcare revenue cycle — 2 experts explain why
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
